Literature DB >> 10747221

Combination of hydrostatic pressure and lacticin 3147 causes increased killing of Staphylococcus and Listeria.

S M Morgan1, R P Ross, T Beresford, C Hill.   

Abstract

The use of hydrostatic pressure and lacticin 3147 treatments were evaluated in milk and whey with a view to combining both treatments for improving the quality of minimally processed dairy foods. The system was evaluated using two foodborne pathogens: Staphylococcus aureus ATCC6538 and Listeria innocua DPC1770. Trials against Staph. aureus ATCC6538 were performed using concentrated lacticin 3147 prepared from culture supernatant. The results demonstrated a more than additive effect when both treatments were used in combination. For example, the combination of 250 MPa (2.2 log reduction) and lacticin 3147 (1 log reduction) resulted in more than 6 logs of kill. Similar results were obtained when a foodgrade powdered form of lacticin 3147 (developed from a spray dried fermentatation of reconstituted demineralized whey powder) was evaluated for the inactivation of L. innocua DPC1770. Furthermore, it was observed that treatment of lacticin 3147 preparations with pressures greater than 400 MPa yielded an increase in bacteriocin activity (equivalent to a doubling of activity). These results indicate that a combination of high pressure and lacticin 3147 may be suitable for improving the quality of minimally processed foods at lower hydrostatic pressure levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747221     DOI: 10.1046/j.1365-2672.2000.00975.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  8 in total

1.  Inhibitory effects of high pressure and heat on Alicyclobacillus acidoterrestris spores in apple juice.

Authors:  Sun-Young Lee; Richard H Dougherty; Dong-Hyun Kang
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

2.  Combined effect of high-pressure treatments and bacteriocin-producing lactic acid bacteria on inactivation of Escherichia coli O157:H7 in raw-milk cheese.

Authors:  Eva Rodriguez; Juan L Arques; Manuel Nuñez; Pilar Gaya; Margarita Medina
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

3.  Use of hydrostatic pressure for inactivation of microbial contaminants in cheese.

Authors:  C E O'Reilly; P M O'Connor; A L Kelly; T P Beresford; P M Murphy
Journal:  Appl Environ Microbiol       Date:  2000-11       Impact factor: 4.792

4.  A Multibacteriocin Cheese Starter System, Comprising Nisin and Lacticin 3147 in Lactococcus lactis, in Combination with Plantaricin from Lactobacillus plantarum.

Authors:  S Mills; C Griffin; P M O'Connor; L M Serrano; W C Meijer; C Hill; R P Ross
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

5.  Relationship between sublethal injury and microbial inactivation by the combination of high hydrostatic pressure and citral or tert-butyl hydroquinone.

Authors:  Maria Somolinos; Diego García; Rafael Pagán; Bernard Mackey
Journal:  Appl Environ Microbiol       Date:  2008-10-24       Impact factor: 4.792

Review 6.  Antimicrobial activity of lactic acid bacteria in dairy products and gut: effect on pathogens.

Authors:  Juan L Arqués; Eva Rodríguez; Susana Langa; José María Landete; Margarita Medina
Journal:  Biomed Res Int       Date:  2015-03-16       Impact factor: 3.411

Review 7.  Bacteriocins: Properties and potential use as antimicrobials.

Authors:  Atieh Darbandi; Arezoo Asadi; Marzieh Mahdizade Ari; Elnaz Ohadi; Malihe Talebi; Masoume Halaj Zadeh; Amir Darb Emamie; Roya Ghanavati; Maryam Kakanj
Journal:  J Clin Lab Anal       Date:  2021-12-01       Impact factor: 2.352

Review 8.  Applications of green technologies-based approaches for food safety enhancement: A comprehensive review.

Authors:  Fakhar Islam; Farhan Saeed; Muhammad Afzaal; Aftab Ahmad; Muzzamal Hussain; Muhammad Armghan Khalid; Shamaail A Saewan; Ashraf O Khashroum
Journal:  Food Sci Nutr       Date:  2022-05-28       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.